Literature DB >> 74832

Evidence for a long-range conformational change induced by antigen binding to IgM antibody.

J C Brown, M E Koshland.   

Abstract

The effects of antigen binding on IgM antibody conformation were investigated by measuring the immunological reactivity of the Fc-bound J polypeptide. For such measurements anti-azophenyl-beta-D-lactoside and anti-azobenzenearsonate IgM antibodies were examined in a J chain radioimmunoassay before and after complexing with various hapten-conjugates. The assays showed that (i) the accessibility of J chain determinants is very limited in uncomplexed IgM and (ii) their accessibility is significantly enhanced in the presence of an excess of specific antigen. In both antibody systems, enhanced J chain exposure was achieved with the homologous multi-hapten-substituted antigen (1.9-fold), with a small multivalent antigen in which three to four hapten groups were coupled to a heterologous carrier (1.55-fold), and with monohapten-substituted antigen (1.4-fold). Because the J chain is located in the terminal CH4 Fc domains, these data provide direct evidence that a change in Fc conformation is induced by the binding of antigen to the distant Fab combining sites. Moreover, the data indicate that the changes in J chain exposure do not depend on crosslinking by antigen, but can be induced by the interaction of antigen at individual IgM combining sites.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 74832      PMCID: PMC431857          DOI: 10.1073/pnas.74.12.5682

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Crystallographic structural studies of a human Fc-fragment. I. An electron-density map at 4 A resolution and a partial model.

Authors:  J Deisenhofer; P M Colman; R Huber; H Haupt; G Schwick
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-03

2.  Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size.

Authors:  J C Jaton; H Huser; D G Braun; D Givol; I Pecht; J Schlessinger
Journal:  Biochemistry       Date:  1975-12-02       Impact factor: 3.162

3.  Changes in intrinsic circular dichroism of several homogeneous anti-type 3 pneumococcal antibodies on binding of a small hapten.

Authors:  D A Holowka; A D Strosberg; J W Kimball; E Haber; R E Cathou
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

4.  The three-dimensional conformation of M and A globulin molecules.

Authors:  A Feinstein; E A Munn; N E Richardson
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

5.  The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten.

Authors:  N E Hyslop; R R Dourmashkin; N M Green; R R Porter
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

6.  Hapten stabilization of antibody conformation.

Authors:  R E Cathou; T C Werner
Journal:  Biochemistry       Date:  1970-08-04       Impact factor: 3.162

7.  Structure and function of the J chain.

Authors:  M E Koshland
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

8.  Site of attachment of J chain to human immunoglobulin M.

Authors:  J Mestecky; R E Schrohenloher
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

9.  Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin.

Authors:  M Feldmann
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation.

Authors:  D M Segal; J D Taurog; H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  9 in total

1.  Assembly and secretion of pentameric IgM in a fusion between a nonsecreting B cell lymphoma and an IgG-secreting plasmacytoma.

Authors:  W C Raschke; E L Mather; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Revisiting the Immunoglobulin Intramolecular Signaling Hypothesis.

Authors:  Anthony Bowen; Arturo Casadevall
Journal:  Trends Immunol       Date:  2016-09-14       Impact factor: 16.687

3.  Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement.

Authors:  J K Wright; J Tschopp; J C Jaton; J Engel
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

4.  Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein.

Authors:  Daqian Sun; M A Accavitti; J D Bryers
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

5.  Induction of an Fc conformational change by binding of antigen: the generation of protein A-reactive sites in chicken immunoglobulin.

Authors:  T Barkas; C M Watson
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

6.  Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

Authors:  Chiara Orlandi; Daniel Deredge; Krishanu Ray; Neelakshi Gohain; William Tolbert; Anthony L DeVico; Patrick Wintrode; Marzena Pazgier; George K Lewis
Journal:  Structure       Date:  2020-03-24       Impact factor: 5.006

7.  Complement activation induced by rabbit rheumatoid factor.

Authors:  R R Meyer; J C Brown
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

8.  Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein.

Authors:  Mohammad Shahrooei; Vishal Hira; Benoit Stijlemans; Rita Merckx; Peter W M Hermans; Johan Van Eldere
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

Review 9.  Ig Constant Region Effects on Variable Region Structure and Function.

Authors:  Alena Janda; Anthony Bowen; Neil S Greenspan; Arturo Casadevall
Journal:  Front Microbiol       Date:  2016-02-04       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.